Nerve Growth Factor Market was valued at USD 1.14 Bn. in 2023 and the market size is expected to grow at a CAGR of 6.99 % through the forecast period.Nerve Growth Factor Market Overview:
The nerve growth factor is a neurotrophic growth factor called neutrophin which supports growth and elasticity of neurons of the peripheral and central nervous system. Nerve growth factor (NGF) is a protein responsible for the development and maintenance of sensory and sympathetic neurons, especially the neurons that transmit touch, temperature, and pain sensation. The nerve growth factor is of several types such as beta-nerve growth factor, gamma- nerve growth factor, alpha- nerve growth factor and others. The nerve growth factor is also associated with type 2 diabetes, obesity, coronary atherosclerosis and other metabolic syndromes.To Know About The Research Methodology :- Request Free Sample Report govern the life cycles of neurons, according to new research. NGF regulates the immune system, which is one of its most important tasks. NGF is released in large concentrations by mass cells as a result of this. Axonal growth occurs in neighboring nociceptive neurons as a result of this. As a result, pain perception is heightened in inflamed areas. NGF has been demonstrated to play a role in romantic and love feelings in more recent studies. The report explores the Nerve Growth Factor Market's segments (Connectivity and Content, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2023. The report investigates the Nerve Growth Factor Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Nerve Growth Factor Market's contemporary competitive scenario.Nerve Growth Factor Market Dynamics:
A rise in the incidence rate of brain illnesses, as well as an increase in the geriatric population, are driving the nerve growth factor market. Detecting targeted blockages, measuring biological response, and determining genetic predisposition are all expected to benefit from expected technology improvements. The nerve growth factor market is projected to be driven by this. However, a rise in stringent regulatory rules, an increase in overall health-care spending, and expensive clinical trial expenses are expected to constrain the nerve growth factor market in the near future. Growing cases of Alzheimer’s disease, corneal ulcer, glaucoma, retinitis pigmentosa which causes tissue damage to the immune system drives the nerve growth factor market. Increased government funding for the innovation of novel treatment and continuous clinical studies using human growth factor for the treatment of various diseases will boost up the global nerve growth factor market.Nerve Growth Factor Market Segment Analysis:
Based on Type Nerve growth factor market is segmented on the bases of the type is Beta NGF, Alpha NGF and Gamma NGF. Beta NGF protein or the Nerve growth factor is mainly involved with the maintenance, growth and proliferation of particular target growth neurons. Gamma NGF subunit plays an important part in this structure. It cleaves the N-terminal that exists within the beta subunit and operates as a serine protease. As such, it is responsible for activating the protein into the typical NGF complex. Alpha-NGF is an inactive serine proteinase. Based on indication Nerve growth factor market is segmented on the bases of the indication is Neurodegenerative disorder, Spinal cord injuries, Eye disorder, Epithelial diseases, Tissue Healing and others. Neurodegenerative disorders, especially Parkinson and Alzheimer NGF is help to cure from these disease. When the spinal cord is damaged, the message from the brain cannot get through. The spinal nerves below the level of injury get signals, but they are not able to go up the spinal tracts to the brain. But NGF is promote nerve cell regeneration or improve the function of the nerves that remain after a spinal cord injury. In eye disorder NGF is used in ocular therapy has been furthest advanced in the treatment of ocular surface disease. NGF is thought to regulate ocular surface homeostasis in multiple ways, including epithelial health, limbal stem cell proliferation, immune modulation, and tear production. Based on route of administration Nerve growth factor market is segmented on the bases of the administration Oral, Occular, Parenteral and other. Oral administration is a route of administration where a substance is taken through the mouth.Ocular administration drugs used to treat eye disorders can be mixed with inactive substances to make a liquid, gel, or ointment so that they can be applied to the eye. Parenteral route is any route that is not enteral. Parenteral administration can be performed by injection, that is, using a needle and a syringe, or by the insertion of an indwelling catheter.Nerve Growth Factor Market Regional Insights:
North America and Europe are expected to rule the global nerve growth factor market due to their huge prevalence and incidence of neurodegenerative diseases. Europe is burdened with brain diseases which account for 35% of the total diseases. The growing awareness and escalating research and clinical progress are expected to further push the nerve growth factor market in North America and Europe. The Asia-Pacific nerve growth factor is expected to grow at a fast pace, driven by the emerging therapies, massive patient base and increasing awareness of brain diseases.Nerve Growth Factor Market Scope: Inquire before buying
Global Nerve Growth Factor Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 1.14 Bn. Forecast Period 2024 to 2030 CAGR: 6.99% Market Size in 2030: USD 1.83 Bn. Segments Covered: by Type Alpha-NGF Beta-NGF Gamma-NGF Others by Application Neurodegenerative Disorders Spinal Cord Injuries Eye Disorders Epithelial Diseases Tissue Healing Others by Administration route Oral Parenteral Ocular Others by End-User Hospitals Specialty Clinics Others Nerve Growth Factor Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Nerve Growth Factor Market, Key Players
1. Dompe pharmaceutical 2. Pfizer Inc. 3. Regeneron 4. Astellas Pharma Inc. 5. Merck KGaA 6. Promega Corporation 7. Alomone Labs 8. Bio-Rad Laboratories, Inc. 9. Enzo Life Sciences, Inc. 10. Prospec-Tany Technogene Ltd. 11. CUSABIO TECHNOLOGY LLC 12. Biocare Medical, LLC. 13. Eli Lilly & Company 14. Teva Pharmaceutical Industries 15. Mitsubishi Tanabe Pharma Corporation 16. Sanofi Frequently Asked Questions: 1] What segments are covered in the Global Market report? Ans. The segments covered in the Global Market report are based on Type, Indication, Administration of route and End user. 2] Which region is expected to hold the highest share in the Global Market? Ans. North America region is expected to hold the highest share in the Global Market. 3] What is the market size of the Global Market by 2030? Ans. The market size of the Global Nerve Growth Factor Market by 2030 is expected to reach USD 1.83 Bn. 4] What is the forecast period for the Global Nerve Growth Factor Market? Ans. The forecast period for the Global Nerve Growth Factor Market is 2024-2030. 5] What was the market size of the Global Nerve Growth Factor Market in 2023? Ans. The market size of the Global Nerve Growth Factor Market in 2023 was valued at USD 1.14 Bn.
1. Global Nerve Growth Factor Market: Research Methodology 2. Global Nerve Growth Factor Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Nerve Growth Factor Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Nerve Growth Factor Market: Competitive Analysis3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Nerve Growth Factor Market Segmentation 4.1 Global Nerve Growth Factor Market, By Type (2023-2030) • Alpha-NGF • Beta-NGF • Gamma-NGF • Others 4.2 Global Nerve Growth Factor Market, By Indication (2023-2030) • Neurodegenerative Disorders • Spinal Cord Injuries • Eye Disorders • Epithelial Diseases • Tissue Healing • Others 4.3 Global Nerve Growth Factor Market, By Administration Route (2023-2030) • Oral • Parenteral • Ocular • Others 4.4 Global Nerve Growth Factor Market, By End user (2023-2030) • Hospitals • Specialty Clinics • Others 5. North America Nerve Growth Factor Market (2023-2030) 5.1 North America Nerve Growth Factor Market, By Type (2023-2030) • Alpha-NGF • Beta-NGF • Gamma-NGF • Others 5.2 North America Nerve Growth Factor Market, By Indication (2023-2030) • Neurodegenerative Disorders • Spinal Cord Injuries • Eye Disorders • Epithelial Diseases • Tissue Healing • Others 5.3 North America Nerve Growth Factor Market, by Administration Route (2023-2030) • Oral • Parenteral • Ocular • Others 5.4 North America Nerve Growth Factor Market, By End user (2023-2030) • Hospitals • Specialty Clinics • Others 5.5 North America Nerve Growth Factor Market, by Country (2023-2030) • United States • Canada • Mexico 6. Asia Pacific Nerve Growth Factor Market (2023-2030) 6.1. Asia Pacific Nerve Growth Factor Market, By Type (2023-2030) 6.2. Asia Pacific Nerve Growth Factor Market, By Indication (2023-2030) 6.3. Asia Pacific Nerve Growth Factor Market, By Administration Route (2023-2030) 6.4. Asia Pacific Nerve Growth Factor Market, By End user (2023-2030) 6.5. Asia Pacific Nerve Growth Factor Market, by Country (2023-2030) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Nerve Growth Factor Market (2023-2030) 7.1 Middle East and Africa Nerve Growth Factor Market, By Type (2023-2030) 7.2. Middle East and Africa Nerve Growth Factor Market, By Indication (2023-2030) 7.3. Middle East and Africa Nerve Growth Factor Market, By Administration Route (2023-2030) 7.4. Middle East and Africa Nerve Growth Factor Market, By End user (2023-2030) 7.5. Middle East and Africa Nerve Growth Factor Market, by Country (2023-2030) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Nerve Growth Factor Market (2023-2030) 8.1. Latin America Nerve Growth Factor Market, By Type (2023-2030) 8.2. Latin America Nerve Growth Factor Market, By Indication (2023-2030) 8.3. Latin America Nerve Growth Factor Market, By Administration Route (2023-2030) 8.4. Latin America Nerve Growth Factor Market, By End user (2023-2030) 8.5. Latin America Nerve Growth Factor Market, by Country (2023-2030) • Brazil • Argentina • Rest of Latin America 9. European Nerve Growth Factor Market (2023-2030) 9.1. European Nerve Growth Factor Market, By Type (2023-2030) 9.2. European Nerve Growth Factor Market, By Indication (2023-2030) 9.3. European Nerve Growth Factor Market, By Administration Route (2023-2030) 9.4. European Nerve Growth Factor Market, By End user (2023-2030) 9.5. European Nerve Growth Factor Market, by Country (2023-2030) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest of Europe 10. Company Profile: Key players 10.1. Sanofi 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Dompe pharmaceutical 10.3 Pfizer Inc. 10.4 Regeneron 10.5 Astellas Pharma Inc. 10.6 Merck KGaA 10.7 Promega Corporation 10.8 Alomone Labs 10.9 Bio-Rad Laboratories, Inc. 10.10 Enzo Life Sciences, Inc. 10.11 Prospec-Tany Technogene Ltd. 10.12 CUSABIO TECHNOLOGY LLC 10.13 Biocare Medical, LLC. 10.14 Eli Lilly & Company 10.15 Teva Pharmaceutical Industries 10.16 Mitsubishi Tanabe Pharma Corporation